What's Behind the Recent Insider Selling at Soleno Therapeutics (SLNO)

Related Articles

What's Behind the Recent Insider Selling at Werewolf Therapeutics (HOWL)

1 months ago

What's Behind the Recent Insider Selling at AnaptysBio

3 months ago

What's Behind the Recent Insider Selling at Vicor

2 months ago

What's Behind the Recent Insider Selling at International Seaways

4 months ago

Category

You may also like

Stock News•3 weeks ago

What a $350,000 Insider Sale Might Mean for Mineralys Ahead of December FDA Decision

Mineralys shares fell after a $350,000 insider sale, ahead of a December FDA decision on its hypertension therapy.

MLYS

Share

Stock News•1 months ago

This Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 Million

Shares of the clinical-stage biotech rose 60% following the advancement of its Phase 3 clinical trial plans for an obesity drug. Meanwhile, an institutional fund divested $4.7M in company stock, signa...

GPCR

Share

Stock News•2 months ago

SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Soleno Therapeutics (NASDAQ: SLNO) faces a class action lawsuit alleging securities fraud for violations of the Securities Exchange Act. Investors who purchased shares between March 26, 2025, and Nove...

SLNO

Share

Stock News•2 months ago

A Kailera Therapeutics (KLRA) Insider Scooped up an Additional 500,000 Shares for $8.0 Million

Kailera Therapeutics (KLRA) insider purchased 500,000 shares for $8.0 million, according to recent SEC filings. This significant acquisition by company leadership signals confidence in the clinical-st...

KLRA

Share